Molecular and Functional Verification of Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency.
Aleksandra Musiał-WysockaMarta KotMaciej SułkowskiBogna BadyraMarcin MajkaPublished in: International journal of molecular sciences (2019)
The properties of mesenchymal stem cells (MSCs), especially their self-renewal and ability to differentiate into different cell lines, are widely discussed. Considering the fact that MSCs isolated from perinatal tissues reveal higher differentiation capacity than most adult MSCs, we examined mesenchymal stem cells isolated from Wharton's jelly of umbilical cord (WJ-MSCs) in terms of pluripotency markers expression. Our studies showed that WJ-MSCs express some pluripotency markers-such as NANOG, OCT-4, and SSEA-4-but in comparison to iPS cells expression level is significantly lower. The level of expression can be raised under hypoxic conditions. Despite their high proliferation potential and ability to differentiate into different cells type, WJ-MSCs do not form tumors in vivo, the major caveat of iPS cells. Owing to their biological properties, high plasticity, proliferation capacity, and ease of isolation and culture, WJ-MSCs are turning out to be a promising tool of modern regenerative medicine.
Keyphrases
- umbilical cord
- mesenchymal stem cells
- induced apoptosis
- poor prognosis
- bone marrow
- cell cycle arrest
- signaling pathway
- cell therapy
- binding protein
- endoplasmic reticulum stress
- risk assessment
- dna methylation
- embryonic stem cells
- cell proliferation
- cell death
- optical coherence tomography
- climate change
- cell fate
- pi k akt
- single molecule
- human health
- case control